Upgrade to SI Premium - Free Trial

Viking Therapeutics (VKTX) Tops Q1 EPS by 2c

April 24, 2024 4:15 PM

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

Categories

Earnings